eccogene glp-1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a receptor agonist for cardio-metabolic diseases New GLP-1 receptor agonists identified
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16







/assets/images/provider/photos/2775905.jpeg)





















